Altered cell cycle regulation in the lens of HPV-16 E6 or E7 transgenic mice: Implications for tumor suppressor gene function in development

Genes and Development

Volumn 8, Issue 11, 1994, Pages 1285-1299

  Pan, Huichin ^a   Griep, Anne E ^a  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

apoptosis; Development; lens; papillomavirus oncogenes; transgenic mice; tumor suppressor genes

Indexed keywords

GENE PRODUCT; ONCOPROTEIN; VIRUS PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CATARACT; CELL DIFFERENTIATION; EMBRYO; GENE EXPRESSION; GENE MUTATION; GROWTH REGULATION; LENS; MOUSE; NONHUMAN; PRIORITY JOURNAL; TRANSGENIC MOUSE; TUMOR SUPPRESSOR GENE; WART VIRUS;

EID: 0028334011     PISSN: 08909369     EISSN: None     Source Type: Journal    
DOI: 10.1101/gad.8.11.1285     Document Type: Article

References (37)

1. Appleby, D.W. and S.P. Modak. 1977. DNA degradation in terminally differentiating lens fiber cells from chick embryos. Proc. Natl Acad. Sci. 74: 5579-5583.
2. Arbeit, J.M., K. Munger, P.M. Howley, and D. Hanahan. 1993. Neuroepithelial carcinomas in mice transgenic with human papillomavirus type 16 E6/E7 ORFs. Am. J. Pathol. 142: 1187-1197.
3. Lambert, P.F., H. Pan, H.C. Pitot, A. Liem, M. Jackson, and A.E. Griep. 1993. Epidermal cancer associated with expression of human papillomavirus type 16 E6 and E7 oncogenes in the skin of transgenic mice. Proc. Natl. Acad. Sci. 90: 5583-5587.
4. Lane, D.P. and L. V. Crawford. 1979. T antigen is bound to a host protein in SV40 transformed cells. Nature 278: 261-263.
5. Lee, E.Y.-H.P., C.-Y. Chang, N. Hu, Y.-C.J. Wang, C.-C.Lai, K. Herrup, W.-H. Lee, and A. Bradley. 1992. Mice deficient for Rb are nonviable and show defects in neurogenesis and haematopoiesis. Nature 359: 288-294.
6. Linzer, D. and A.J. Levine. 1979. Characterization of a 54 kd cellular SV40 tumor antigen present in SV40-transformed cells and uninfected embryonal carcinoma cells. Cell 17: 43-52.
7. Lowe, S.W. and H.E. Ruley. 1993. Stabilization of the p53 tumor suppressor is induced by adenovirus 5 E1A and accompanies apoptosis. Genes & Dev. 7: 535-545.
8. Lowe, S.W., E.M. Schmitt, S.W. Smith, B.A. Osborne, and T. Jacks. 1993. p53 is required for radiation-induced apoptosis in mouse thymocytes. Nature 362: 847-849.
9. Mahon, K.A., A.B. Chepelinsky, J.S. Khillan, P.A. Overbeek, J. Piatigorsky, and H. Westphal. 1987. Oncogenesis of the lens in transgenic mice. Science 235: 1622-1628.
10. Matlashewski, G., J. Schneider, L. Banks, N. Jones, A. Murray, and L. Crawford. 1987. Human papillomavirus type 16 DNA cooperates with activated ras in transforming primary cells. EMBO J. 6: 1741-1746.
11. McAvoy, J.W. 1978. Cell division, cell elongation and the coordination of crystallin gene expression during lens morphogenesis in the rat. J. Embryol. Exp. Morph. 45: 271-281.
12. Mercer, W.E., M.T. Shields, D. Lin, E. Appella, and S.J. Ullrich. 1991. Growth suppression induced by wild-type p53 protein is accompanied by selective down-regulation of proliferating-cell nuclear antigen expression. Proc. Natl. Acad. Sci. 88: 1958-1962.
13. Mietz, J.A., T. Unger, J.M. Huibregtse, and P.M. Howley. 1992. The transcriptional transactivation function of the wild type p53 is inhibited by SV40 large T antigen and by HPV-16 E6 oncoprotein. EMBO J. 11: 5013-5020.
14. Morris, G.F. and M.B. Mathews. 1989. Regulation of proliferating cell nuclear antigen during the cell cycle. J. Biol. Chem. 264: 13856-13864.
15. Munger, K., B.A. Werness, N. Dyson, W.C. Phelps, E. Harlow, and P.M. Howley. 1989a. Complex formation of human papillomavirus E7 proteins with the retinoblastoma tumor suppressor gene product. EMBO J. 8: 4099-4105.
16. Munger, K., W.C. Phelps, V. Bubb, P.M. Howley, and R. Schlegel. 1989b. The E6 and E7 genes of the human papillomavirus type 16 together are necessary and sufficient for transformation of primary human keratinocytes. J. Virol. 63: 4417-4421.
17. Nevins, J.R. 1992. E2F: A link between the Rb tumor suppressor protein and viral oncoproteins. Science 258: 424-429.
18. Noda, A., Y. Ning, S.F. Venable, O.M. Perreira-Smith, and J.R. Smith. 1994. Cloning of senecent cell-derived inhibitors of DNA synthesis using an expression screen. Exp. Cell Res. 211: 90-98.
19. Phelps, W.C. and P.M. Howley. 1987. Transcriptional trans-activation by the human papillomavirus type 16 E2 gene product. J. Virol. 61: 1630-1638.
20. Phelps, W.C., C.L. Yee, K. Munger, and P.M. Howley. 1988. The human papillomavirus type 16 E7 gene endcodes transactivation and transformation functions similar to those of adenovirus E1A. Cell 53: 539-547.
21. Phelps, W.C., K. Munger, C.L. Yee, J.A. Barnes, and P.M. Howley. 1992. Structure-function analysis of the human papillomavirus type 16 E7 oncoprotein. J. Virol. 66: 2418-2427.
22. Rao, L., M. Debbas, P.Sabbatinin, D. Hockenbery, S. Korsmeyer, and E. White. 1992. The adenovirus E1A proteins induce apoptosis which is inhibited by the E1B 19K and Bcl-2 proteins. Proc. Natl. Acad. Sci. 89: 7742-7746.
23. Rogel, A., M. Popliker, G.G. Webb, and M. Oren. 1985. p53 cellular tumor antigen: Analysis of mRNA levels in normal adult tissues, embryos, and tumors. Mol. Cell. Biol. 5: 2851-2855.
24. Sarnow, P., Y.S. Ho, J. Williams, and A.J. Levine. 1982. Adenovirus E1B-58 kd tumor antigen and SV40 T antigen are physically associated with the same 54 kd cellular protein in transformed cells. Cell 28: 387-394.
25. Scheffner, M., B.A. Werness, J.M. Huibregtse, A.J. Levine, and P.M. Howley. 1990. The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53. Cell 63: 1129-1136.
26. Schmid, P., A. Lorenz, H. Hameister, and M. Montenarh. 1991. Expression of p53 during mouse embryogenesis. Development 113: 857-865.
27. Sedman, S.A., M.S. Barbosa, W.C. Vass, N.L. Hubbert, J.A. Haas, D.R. Lowy, and J.T. Schiller. 1991. The full length E6 protein of HPV-16 has transforming and transactivating activities and cooperates with E7 to immortalize keratinocytes in culture. J. Virol. 65: 4860-4866.
28. Sedman, S.A., N.L. Hubbert, W.C. Vass, D.R. Lowy, and J.T. Schiller. 1992. Mutant p53 can substitute for human papillomavirus type 16 E6 in immortalization of human keratinocytes but does not have E6-associated trans-activation or transforming activity. J. Virol. 66: 4201-4208.
29. Storey, A. and L. Banks. 1993. Human papillomavirus type 16 E6 gene cooperates with EJ-ras to immortalize primary mouse cells. Oncogene 8: 919-924.
30. Storey, A., D. Pim, A. Murray, K. Osborn, L. Banks, and L. Crawford. 1988. Comparison of the in vitro transforming activities of human papillomavirus types. EMBO J. 7: 1815-1820.
31. Tilly, J.L. and A.J.W. Hsueh. 1993. Microscale autoradiographic method for the qualitative and quantitative analysis of apoptotic DNA fragmentation. J. Cell. Physiol. 154: 519-526.
32. Walker, P.R., L. Kokileva, J. LeBlanc, and M. Sikorska. 1993. Detection of the initial stages of DNA fragmentation in apoptosis. BioTechniques 15: 1032-1040.
33. Werness, B.A., A.J. Levine, and P.M. Howley. 1990. Association of human papillomavirus types 16 and 18 E6 proteins with p53. Science 248: 76-79.
34. Whyte, P., K.J. Buchkovich, J.M. Horowitz, S.H. Friend, M. Raybuck, R. Weinberg, and E. Harlow. 1988. Association between an oncogene and an anti-oncogene: The adenovirus E1a proteins bind to the retinoblastoma gene product. Nature 334: 124-129.
35. Woodworth, C.D., S. Waggoner, W. Barnes, M.H. Stoler, and J.A. DiPaolo. 1990. Human cervical and foreskin epithelial cells immortalized by human papillomavirus DNAs exhibit dysplastic differentiation in vivo. Cancer Res. 50: 3709-3715.
36. Wyllie, A.H. 1980. Glucocorticoid-induced thymocyte apoptosis is associated with endonuclease activation. Nature 284: 555-556.
37. Xiong, Y., G.J. Hannon, H. Zhang, D. Casso, R. Kobayashi, and D. Beach. 1993. p21 is a universal inhibitor of cyclin kinases. Nature 366: 701-704.